Skip to content
healthcare.dev

Omeprazole

NDC 83324-011, Omeprazole, tablet, delayed release, from CHAIN DRUG MARKETING ASSOCIATION, INC..

Product NDC
83324-011
Status
Listed
Labeler
CHAIN DRUG MARKETING ASSOCIATION, INC.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA211732
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83324-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMEPRAZOLE20 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
83324-011-14833240011141 CONTAINER in 1 CARTON (83324-011-14) / 14 TABLET, DELAYED RELEASE in 1 CONTAINER
83324-011-42833240011423 CONTAINER in 1 CARTON (83324-011-42) / 14 TABLET, DELAYED RELEASE in 1 CONTAINER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83324-011 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83324-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83324-011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.